Article
Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment.
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
Journal of Alzheimer's disease: JAD (impact factor:
3.74).
01/2012;
28(2):389-402.
DOI:10.3233/JAD-2011-111313
pp.389-402
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Concerted perturbation observed in a hub network in Alzheimer's disease.
[show abstract] [hide abstract]
ABSTRACT: Alzheimer's disease (AD) is a progressive neurodegenerative disease involving the alteration of gene expression at the whole genome level. Genome-wide transcriptional profiling of AD has been conducted by many groups on several relevant brain regions. However, identifying the most critical dys-regulated genes has been challenging. In this work, we addressed this issue by deriving critical genes from perturbed subnetworks. Using a recent microarray dataset on six brain regions, we applied a heaviest induced subgraph algorithm with a modular scoring function to reveal the significantly perturbed subnetwork in each brain region. These perturbed subnetworks were found to be significantly overlapped with each other. Furthermore, the hub genes from these perturbed subnetworks formed a connected hub network consisting of 136 genes. Comparison between AD and several related diseases demonstrated that the hub network was robustly and specifically perturbed in AD. In addition, strong correlation between the expression level of these hub genes and indicators of AD severity suggested that this hub network can partially reflect AD progression. More importantly, this hub network reflected the adaptation of neurons to the AD-specific microenvironment through a variety of adjustments, including reduction of neuronal and synaptic activities and alteration of survival signaling. Therefore, it is potentially useful for the development of biomarkers and network medicine for AD.PLoS ONE 01/2012; 7(7):e40498. · 4.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
AD patients
Alzheimer's disease
amyloid plaques
cellular machinery
damage-themed hypothesis
different stages
distinctive stages
elevated apoptosis
human postmortem brain tissues
intriguing down-regulation patterns
low level
mitochondrion damage
observed pathological features
oxidative stress
oxygen supply
pharmaceutical intervention
reduced level
signal transduction
time evolution
transcriptome studies